Literature DB >> 22095788

Human testis-derived embryonic stem cell-like cells are not pluripotent, but possess potential of mesenchymal progenitors.

J V Chikhovskaya1, M J Jonker, A Meissner, T M Breit, S Repping, A M M van Pelt.   

Abstract

BACKGROUND: Spontaneous in vitro transition of undifferentiated spermatogonia into the pluripotent cell state has been achieved using neonatal and adult mouse testis tissue. In an effort to establish an analogous source of human patient-specific pluripotent stem cells, several research groups have described the derivation of embryonic stem cell-like cells from primary cultures of human testis. These cells are characterized in all studies as growing in compact colonies, expressing pluripotency-associated markers and possessing multilineage differentiation capabilities in vitro, but only one study claimed their ability to induce teratomas. This controversy initiated a debate about the pluripotent state and origin of human testis-derived ES-like cells (htES-like cells).
METHODS: htES-like cell colonies were obtained from primary testicular cultures of three individuals and selectively expanded using culture conditions known to support the propagation of blastocyst-derived human embryonic stem cells (ESCs), mouse epiblast stem cells and 'naïve' human ESCs. The stem cell properties of htES-like cells were subsequently assessed by testing the expression of ESC-specific markers, differentiation abilities in vitro and in vivo, and microarray profiling.
RESULTS: The expression of pluripotency-associated markers in htES-like cells and their differentiation abilities differed significantly from those of ESCs. Gene expression microarray analysis revealed that htES-like cells possess a transcriptome distinct from human ESCs and fibroblasts, but closely resembling the transcriptome of mesenchymal stem cells (MSCs). The similarity to MSCs was confirmed by detection of SSEA4/CD146 expressing cells within htES-like colonies and efficient in vitro differentiation toward three mesodermal lineages (adipogenic, osteogenic, chondrogenic).
CONCLUSIONS: Taken together, these results indicate that htES-like cells, in contrast to pluripotent stem cells derived from adult mouse testis, are not pluripotent and most likely not of germ cell but of mesenchymal origin.

Entities:  

Mesh:

Year:  2011        PMID: 22095788     DOI: 10.1093/humrep/der383

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  23 in total

Review 1.  Current stem cell based therapies in diabetes.

Authors:  Meredith A Lilly; Meghan F Davis; Josh E Fabie; Elizabeth B Terhune; G Ian Gallicano
Journal:  Am J Stem Cells       Date:  2016-10-20

Review 2.  Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review.

Authors:  Zahra Fazeli; Atieh Abedindo; Mir Davood Omrani; Sayyed Mohammad Hossein Ghaderian
Journal:  Stem Cell Rev Rep       Date:  2018-02       Impact factor: 5.739

Review 3.  Spermatogonial stem cells.

Authors:  Hiroshi Kubota; Ralph L Brinster
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

4.  Pluripotent Conversion of Muscle Stem Cells Without Reprogramming Factors or Small Molecules.

Authors:  Bipasha Bose; Sudheer Shenoy P
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

5.  Spermatogonial stem cells: Current biotechnological advances in reproduction and regenerative medicine.

Authors:  Pedro Manuel Aponte
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

6.  Testicular niche required for human spermatogonial stem cell expansion.

Authors:  James F Smith; Pamela Yango; Eran Altman; Shweta Choudhry; Andrea Poelzl; Alberuni M Zamah; Mitchell Rosen; Peter C Klatsky; Nam D Tran
Journal:  Stem Cells Transl Med       Date:  2014-07-18       Impact factor: 6.940

7.  Characterization of human spermatogonial stem cell markers in fetal, pediatric, and adult testicular tissues.

Authors:  Eran Altman; Pamela Yango; Radwa Moustafa; James F Smith; Peter C Klatsky; Nam D Tran
Journal:  Reproduction       Date:  2014-07-16       Impact factor: 3.906

8.  Isolation and characterization of novel, highly proliferative human CD34/CD73-double-positive testis-derived stem cells for cell therapy.

Authors:  Won Yun Choi; Hwang Gyun Jeon; Young Chung; Jung Jin Lim; Dong Hyuk Shin; Jung Mo Kim; Byeong Seong Ki; Seung-Hun Song; Seong-Jun Choi; Keun-Hong Park; Sung Han Shim; Jisook Moon; Sung Jun Jung; Hyun Mi Kang; Seah Park; Hyung Min Chung; Jung Jae Ko; Kwang Yul Cha; Tae Ki Yoon; Haekwon Kim; Dong Ryul Lee
Journal:  Stem Cells Dev       Date:  2013-05-03       Impact factor: 3.272

9.  The pluripotency factor LIN28 in monkey and human testes: a marker for spermatogonial stem cells?

Authors:  N Aeckerle; K Eildermann; C Drummer; J Ehmcke; S Schweyer; A Lerchl; M Bergmann; S Kliesch; J Gromoll; S Schlatt; R Behr
Journal:  Mol Hum Reprod       Date:  2012-06-11       Impact factor: 4.025

10.  False-positive antibody signals for the pluripotency factor OCT4A (POU5F1) in testis-derived cells may lead to erroneous data and misinterpretations.

Authors:  R Warthemann; K Eildermann; K Debowski; R Behr
Journal:  Mol Hum Reprod       Date:  2012-08-29       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.